NCT Number: NCT05689021
Phase:
Trial Summary: This phase II trial tests how well abiraterone acetate/niraparib (CJNJ-67652000 [niraparib/abiraterone acetate fixed-dose combination]) and prednisone works in treating patients with castration-resi – clinicaltrials.gov for more information and location
Clinicaltrials.gov
Trial Sponsor(s): Mayo Clinic
Acronym:
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives